Acumen Pharmaceuticals Newsroom

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

GlobeNewswireNov 27 05:00

Does Acumen Pharmaceuticals (NASDAQ:ABOS) Have A Healthy Balance Sheet?

Simply Wall StNov 16 20:45

BofA Securities Maintains Acumen Pharmaceuticals(ABOS.US) With Buy Rating

Futu NewsNov 13 23:33 · Ratings

Express News | Acumen Pharmaceuticals Inc : BofA Global Research Cuts Price Objective to $12 From $14

BreakingsNov 13 23:14

H.C. Wainwright Maintains Acumen Pharmaceuticals(ABOS.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 13 20:31 · Ratings

Acumen Pharmaceuticals Advances Alzheimer's Therapeutic

TipRanksNov 13 12:37

Acumen Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 13 05:33 · Announcements

Acumen Pharmaceuticals' Shares Drop on Wider 3Q Loss

WSJNov 13 03:09

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 13 02:20 · Conference Call

Acumen Pharmaceuticals | 8-K: Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights

SECNov 13 01:18

Express News | Acumen Pharmaceuticals, Inc. Q3 Basic EPS USD -0.5

BreakingsNov 12 20:00

Express News | Acumen Pharmaceuticals, Inc. Q3 Net Income USD -29.765 Million

BreakingsNov 12 20:00

Earnings Preview: ABOS to Report Financial Results Pre-market on November 12

$Acumen Pharmaceuticals(ABOS.US)$ is scheduled to release its financial results pre-market on November 12 ET. Earnings PreviewAnalysts estimate $Acumen Pharmaceuticals(ABOS.US)$ to post revenue of

Futu NewsNov 7 09:00

Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

GlobeNewswireNov 7 05:00

Express News | Acumen Pharmaceuticals Appoints DR. Amy Schacterle as Chief Regulatory Officer & Head of Quality

BreakingsNov 6 21:00

Press Release: Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality

Dow JonesNov 6 21:00

Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024

GlobeNewswireNov 6 05:00

Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug

BenzingaOct 31 20:14

Express News | Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17TH Annual Clinical Trials on Alzheimer’s Disease (Ctad) Conference

BreakingsOct 23 20:00

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

GlobeNewswireOct 23 20:00